Article Details

VelosBio raises $58M in Series A round for antibody-drug conjugate development

Retrieved on: 2018-10-02 22:37:30

Tags for this article:

Click the tags to see associated articles and topics

VelosBio raises $58M in Series A round for antibody-drug conjugate development. View article details on hiswai:

Excerpt

<div>The other leader was <b>Sofinnova Ventures</b>, while Pappas Ventures and Chiesi Ventures participated, along with existing investors Takeda Ventures ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo